910 filings
Page 34 of 46
DEF 14A
ARMP
Armata Pharmaceuticals, Inc.
Definitive proxy
21 Nov 07
12:00am
CORRESP
ARMP
Armata Pharmaceuticals, Inc.
13 Nov 07
Correspondence with SEC
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
8 Nov 07
Letter from SEC
12:00am
PRE 14A
ARMP
Armata Pharmaceuticals, Inc.
Preliminary proxy
6 Nov 07
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
5 Nov 07
Targeted Genetics Reports Third Quarter 2007 Financial Results
12:00am
10-Q
2007 Q3
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
31 Oct 07
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
18 Sep 07
TARGETED GENETICS REPORTS ON RECOMBINANT DNA ADVISORY COMMITTEE (RAC) REVIEW OF ITS PHASE 1/2 TRIAL OF tgAAC94 FOR RHEUMATOID ARTHRITIS
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
10 Aug 07
Targeted Genetics Reports Second Quarter 2007 Financial Results
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
7 Aug 07
Other Events
12:00am
10-Q
2007 Q2
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
7 Aug 07
12:00am
424B3
ARMP
Armata Pharmaceuticals, Inc.
31 Jul 07
Prospectus supplement
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
30 Jul 07
Other Events
12:00am
EFFECT
ARMP
Armata Pharmaceuticals, Inc.
30 Jul 07
Notice of effectiveness
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
25 Jul 07
Other Events
12:00am
S-3
ARMP
Armata Pharmaceuticals, Inc.
Shelf registration
11 Jul 07
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
28 Jun 07
Targeted Genetics Completes $19.5 Million
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
25 Jun 07
Targeted Genetics Announces $19.5 Million Private Placement of Common Stock
12:00am
S-8
ARMP
Armata Pharmaceuticals, Inc.
8 Jun 07
Registration of securities for employees
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
4 Jun 07
Targeted Genetics Reports Additional Data from
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
24 May 07
TARGETED GENETICS COMPLETES ENROLLMENT AND INITIAL DOSING OF tgAAC94 PHASE I/II TRIAL IN PATIENTS WITH INFLAMMATORY ARTHRITIS
12:00am